anti-Tumor Necrosis Factor, alpha-Induced Protein 2 (TNFAIP2) Antikörper

TNFAIP2 was identified as a gene whose expression can be induced by the tumor necrosis factor alpha (TNF) in umbilical vein endothelial cells. Zusätzlich bieten wir Ihnen TNFAIP2 Kits (9) und TNFAIP2 Proteine (4) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
TNFAIP2 21928 Q61333
TNFAIP2 299339  
TNFAIP2 7127 Q03169
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-TNFAIP2 Antikörper auf antikoerper-online.de

Showing 10 out of 66 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Lieferzeit Preis Details
Hund Kaninchen Unkonjugiert WB Host: Rabbit Target Name: TNFAIP2 Sample Tissue: Human MCF7 Whole Cell Antibody Dilution: 1ug/ml 100 μL 2 bis 3 Tage
$289.00
Details
Human Kaninchen Unkonjugiert IF, ELISA, WB 0.1 mg 2 bis 3 Tage
$370.00
Details
Human Kaninchen Unkonjugiert IF, IHC, ELISA Immunohistochemistry analysis of paraffin-embedded human liver carcinoma tissue, using TNAP2 Antibody. The picture on the right is treated with the synthesized peptide. Immunofluorescence analysis of HuvEc cells, using TNAP2 Antibody. The picture on the right is treated with the synthesized peptide. 100 μg 2 bis 3 Tage
$324.50
Details
Human Kaninchen Unkonjugiert EIA, FACS, IHC (p), WB Flow Cytometry analysis of HepG2 cells using TNFAIP2 Antibody (Center) Cat.-No AP17795PU-N  (bottom histogram) compared to a negative control cell (top histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis. Immunohistochemistry analysis in formalin fixed and paraffin embedded human lymphnode using TNFAIP2 Antibody (Center) Cat.-No AP17795PU-N followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the TNFAIP2 Antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated. 0.4 mL 6 bis 8 Tage
$522.50
Details
Human Kaninchen Unkonjugiert ELISA, IF, IHC, IHC (p) 100 μL 11 bis 14 Tage
$493.17
Details
Human Kaninchen Unkonjugiert ELISA, ICC, IF, IHC ABIN6266916 at 1/100 staining human kidney tissue sections by IHC-P. The tissue was formaldehyde fixed and a heat mediated antigen retrieval step in citrate buffer was performed. The tissue was then blocked and incubated with the antibody for 1.5 hours at 22°C. An HRP conjugated goat anti-rabbit antibody was used as the secondary. ABIN6266916 staining A549 cells by IF/ICC. The sample were fixed with PFA and permeabilized in 0.1% Triton X-100,then blocked in 10% serum for 45 minutes at 25°C. The primary antibody was diluted at 1/200 and incubated with the sample for 1 hour at 37°C. An Alexa Fluor 594 conjugated goat anti-rabbit IgG (H+L) antibody(Cat.# S0006), diluted at 1/600, was used as secondary antibody. 100 μL 11 bis 12 Tage
$390.77
Details
Human Kaninchen Unkonjugiert EIA, IF, WB   0.1 mg 4 bis 8 Tage
$539.00
Details
Human Kaninchen Unkonjugiert IF (p), IHC (p), WB Mouse liver lysates probed with Rabbit Anti-TNFAIP2 Polyclonal Antibody, Unconjugated  at 1:5000 for 90 min at 37˚C. Antigen: 0.2 µg/100 µL  Primary: Antiserum, 1:500, 1:1000, 1:2000, 1:4000, 1:8000, 1:16000, 1:32000;  Secondary: HRP conjugated Goat-Anti-Rabbit IgG at 1: 5000;  TMB staining;  Read the data in MicroplateReader by 450 100 μL 3 bis 7 Tage
$327.80
Details
Human Kaninchen Unkonjugiert WB 100 μg 2 bis 3 Tage
$258.46
Details
Human Kaninchen Unkonjugiert ELISA, WB Western blot analysis of TNFAIP2 in K-562 cell lysate with TNFAIP2 polyclonal antibody  at 1 ug/mL in (1) the absence and (2) the presence of blocking peptide. 100 μg 11 bis 12 Tage
$460.00
Details

Weitere Antikörper gegen TNFAIP2 Interaktionspartner

Mouse (Murine) Tumor Necrosis Factor, alpha-Induced Protein 2 (TNFAIP2) Interaktionspartner

  1. Knockdown of TNFaip2 in Raw264.7 cells inhibited formation of tunneling nanotubes.

Human Tumor Necrosis Factor, alpha-Induced Protein 2 (TNFAIP2) Interaktionspartner

  1. ERp29-MSec interaction appeared to require the presence of other bridging protein(s), perhaps triggered by post-translational modification of ERp29

  2. The expression of TNFAIP2 is frequently abnormal in human cancers and in infectious diseases. Due to its significant functions in cell proliferation, angiogenesis, migration and invasion, TNFAIP2 could be a potential diagnostic biomarker and therapeutic target for cancer.

  3. Study investigates the role of miR-221 in the inflammatory response and neuronal apoptosis following spinal cord I/R and the potential participation of TNFAIP2 signaling in oxygen-glucose deprivation (OGD)-stressed neuronal cell lines. TNFAIP2 overexpression reversed the inflammatory response and cell apoptosis induced by miR-221 under OGD stress.

  4. A polarized secretion assay suggested that the silencing of endothelial myeloid-secretory impairs T effector transendothelial migration by reducing the preferential secretion of endothelial-produced CCL2.

  5. Data indicate that TNFAIP2 overexpression may facilitate proliferation and metastasis via activation of the Wnt/beta-catenin signaling pathway in esophageal squamous cell carcinoma.

  6. Taken together, genome-wide chromatin analysis of Legionella pneumophila-infected macrophages demonstrated induction of TNFAIP2, a NF-kappaB-dependent factor relevant for bacterial replication.

  7. data suggest that TNFAIP2 is a novel inhibitor of NF-kappa-B that acts as an autoinhibitor of the TNFalpha response during septic shock.

  8. findings collectively suggest that TNFAIP2 is a direct KLF5 target gene, and both KLF5 and TNFAIP2 promote breast cancer cell proliferation, migration and invasion through Rac1 and Cdc42

  9. A functional TNFAIP2 3'-UTR rs8126 genetic polymorphism contributes to risk of esophageal squamous cell carcinoma.

  10. the regulation of TNFAIP2 and its role in promoting NPC tumor progression

  11. The TNFAIP2 miRNA binding site rs8126 T>C single nucleotide polymorphism may be a marker for susceptibility to gastric cancer.

  12. A functional variant at the miR-184 binding site in TNFAIP2 is associated with squamous cell carcinoma of the head and neck.

  13. TNFAIP2 may serve as a useful new marker of dendritic and histiocytic sarcomas.

  14. TNFAIP2 is a target gene of the BACH1 transcription factor according to ChIP-seq analysis in HEK 293 cells.

  15. TNFAIP2 is a cell migration-promoting protein and its expression predicts distant metastasis. Our data suggest that TNFAIP2 may serve as an independent prognostic indicator for nasopharyngeal carcinoma.

TNFAIP2 Antigen-Profil

Protein Überblick

This gene was identified as a gene whose expression can be induced by the tumor necrosis factor alpha (TNF) in umbilical vein endothelial cells. The expression of this gene was shown to be induced by retinoic acid in a cell line expressing a oncogenic version of the retinoic acid receptor alpha fusion protein, which suggested that this gene may be a retinoic acid target gene in acute promyelocytic leukemia.

Genbezeichner und Symbole assoziert mit TNFAIP2

  • tumor necrosis factor, alpha-induced protein 2 (Tnfaip2) Antikörper
  • TNF alpha induced protein 2 (Tnfaip2) Antikörper
  • TNF alpha induced protein 2 (TNFAIP2) Antikörper
  • B94 Antikörper
  • EXOC3L3 Antikörper
  • M-sec Antikörper
  • tnfb94 Antikörper
  • Tnfip2 Antikörper

Bezeichner auf Proteinebene für TNFAIP2

TNF alpha-induced protein 2 , primary response gene B94 protein , tumor necrosis factor alpha-induced protein 2 , tumor necrosis factor induced protein 2 , exocyst complex component 3-like 3

GENE ID SPEZIES
21928 Mus musculus
299339 Rattus norvegicus
7127 Homo sapiens
480440 Canis lupus familiaris
786672 Bos taurus
Ausgewählte Anbieter für anti-TNFAIP2 (TNFAIP2) Antikörper
Haben Sie etwas anderes gesucht?